[ad_1]
In 2020 we launched a brand new sequence titled “5 Questions With…” in an effort to highlight people from throughout the BioHealth Capital Area and past. Offering this platform has allowed us to assist share the tales of business friends and present that there isn’t a single “proper” solution to changing into an business success.
Because the 12 months wraps up and we stay up for 2021, we’re additionally wanting again to the 30 visitors we’ve featured on this sequence. From CFOs to Scientists, Veterans to Enterprise Capitalists, Firm Founders to Management who not too long ago joined their present corporations, and everybody inbetween.
Should you suppose you’d be a very good visitor for our “5 Questions With…” sequence, or wish to counsel any individual – please tell us!
E-mail Andy Eckert to get the method began: andy(at)biobuzz.io
John Trainer, CFO, NexImmune, Inc.
John has over 20 years of expertise in varied monetary, transactional, strategic, and business roles within the biopharma business. His most up-to-date roles earlier than becoming a member of NexImmune have been Vice President and Head of Partnering & Technique for MedImmune, and Vice President, Company Growth for AstraZeneca. Mr. Coach acquired his MBA from Harvard Enterprise College, his AB from Harvard Faculty, and lives along with his household (and canine) in McLean.
Byung Ha Lee, Director, R&D at NeoImmuneTech, Inc.
Byung Ha Lee is the Director, R&D at NeoImmuneTech, Inc. With levels from Korea College, and his Ph.D. in Medical Sciences-immunology and microbiology from the College of Florida Faculty of Drugs. He has intensive business expertise over 15 years in translational analysis, enterprise growth, area KOL interplay, main strategic and analysis planning of drug growth. Byung Ha completed his postdoctoral coaching on the NIAID at NIH.
Jennifer Butler, Executive Vice President and General Manager of Innate Pharma U.S.
Jennifer Butler was appointed Govt Vice President and Basic Supervisor of Innate Pharma US Inc. in March 2019. Previous to her appointment, Ms. Butler served as Chief Enterprise Officer, Chief Industrial Officer, and Head of US operations, answerable for international enterprise growth and business technique at Tessa Therapeutics, a clinical-stage oncology firm. She beforehand served for greater than 10 years in varied business and technique roles with growing accountability at AstraZeneca/MedImmune throughout a number of therapeutic areas. Ms. Butler additionally beforehand labored in strategic healthcare consulting and as an analyst in Fairness Capital Markets at Merrill Lynch. Ms. Butler has greater than 20 years of strategic advertising and marketing and business management experience together with basic administration expertise.
Stephanie Duatschek, Biopharma Executive Management Consultant
Stephanie has over 20 years of expertise in varied strategic and operational roles spanning medical growth, portfolio administration, and business operations within the biopharma business. She has spent the final 6 years as a marketing consultant partnering with C-suite executives primarily within the business area. Previous to launching her consulting enterprise, Stephanie was Vice President of Industrial Operations for MedImmune. She is Adjunct College at Georgetown College the place she lectures on Commercialization Technique. Stephanie acquired her MBA from The Fuqua College of Enterprise and lives together with her household in Arlington.
Dan Gincel, Ph.D., Executive Director, MD Stem Cell Research Fund at TEDCO
In his twin roles as Vice President for College Partnerships on the Maryland Expertise Growth Company (TEDCO) and Govt Director of the Maryland Stem Cell Analysis Fund (MSCRF), Dr. Gincel oversees applications on college analysis, tech switch, commercialization, and innovation that contribute to Maryland’s financial development. His expertise in and out of doors of the laboratory has made him a confirmed chief and champion for college analysis and growth. He’s devoted to growing analysis capability for Maryland scientists, supporting cutting-edge know-how growth, and in the end, creating cures for debilitating ailments. Dan acquired his BS and Ph.D. in biochemistry and neuroscience from the Ben-Gurion College, Israel, and his postdoctoral fellowship at Johns Hopkins College.
Nikki Hastings, Executive Director, CvilleBioHub
Nikki Hastings is the manager director of CvilleBioHub in Charlottesville, Virginia working to strengthen and develop the regional biotechnology business ecosystem. Over the previous decade, she has contributed to the expansion of early-stage corporations together with HemoShear Therapeutics and Contraline by main operational and development wants and supporting the interpretation of analysis ideas into business viability. Nikki holds a Ph.D. in biomedical engineering from the College of Virginia and a B.S. from North Carolina State College in the identical area.
Aaron Vernon, VP of Engineering & Supply Chain, Autolus
Aaron is a passionate builder with over 20 years of expertise in provide chain administration, manufacturing, enterprise course of growth, organizational transformation, and facility design/building at Johnson & Johnson, MedImmune, AstraZeneca, Sucampo, and Autolus. He’s at the moment Vice President of Engineering & Provide Chain at Autolus, Inc, the place he and his crew are answerable for constructing and orchestrating Autolus’ international provide community.
Alison Demarest, Principal, Meridian BioGroup
Alison Demarest has greater than 30 years of expertise in biotechnology and FDA-regulated industries underneath GMP and GLP in each consulting and working corporations, together with contract manufacturing and contract testing. She is the co-founder of Meridian BioGroup, a compliance, regulatory and validation service-provider to the Maryland biopharm neighborhood in its 14th 12 months.
Shruti Abbato, EVP, Business Development, CARMA Cellular Therapies at MaxCyte, Inc.
Shruti has 20 years of enterprise growth expertise within the biotechnology business. She is at the moment answerable for constructing and rising MaxCyte’s CARMA Cell Therapies enterprise. Earlier than MaxCyte, she labored with Celdara Medical, Millendo, Medigene, Deciphera, and Human Genome Sciences. Shruti holds an MBA from the College of Pittsburgh and a BS in Chemical Engineering and Biochemistry from the College of Maryland.
Sara Nayeem, M.D., a Partner at New Enterprise Associates (NEA)
Sara Nayeem, M.D. is a Associate at New Enterprise Associates (NEA), a big diversified enterprise capital agency. Sara joined NEA’s healthcare crew in 2009 and focuses on investments in biopharmaceutical corporations. She serves on the boards of Centrexion, Complexa, Cydan, Imara (IMRA), Tiburio, and a stealth focused oncology firm.
Cara Felish, VP, Commercial Operations, Aurinia Pharmaceuticals
Sara Nayeem, M.D. is a Associate at New Enterprise Associates (NEA), a big diversified enterprise capital agency. Sara joined NEA’s healthcare crew in 2009 and focuses on investments in biopharmaceutical corporations. She serves on the boards of Centrexion, Complexa, Cydan, Imara (IMRA), Tiburio, and a stealth focused oncology firm.
Jamie Lacey-Moreira, Principal and Founder, PressComm PR, LLC
Jamie Lacey-Moreira has 25 years of expertise offering devoted communications service to commerce associations and life science corporations from start-up by way of commercialization. She established PressComm PR, LLC in 2009 and in addition serves as a part of the Sam Brown Inc. strategic communications crew. Earlier than beginning PressComm, she spent practically seven years constructing the general public relations division at MedImmune (now the biologics division of AstraZeneca). Beforehand, she managed communications features at Celera Genomics and Novartis Company in addition to the Nationwide Council of Farmer Cooperatives and the American Affiliation of Motor Car Directors.
Jeff Galvin, CEO, and Founder of American Gene Technologies™
Jeff Galvin is the CEO and Founding father of American Gene Applied sciences™ (AGT). He earned his BA diploma in Economics from Harvard in 1981 and has greater than 30 years of enterprise and entrepreneurial expertise together with founder or government positions at a wide range of Silicon Valley startups. A number of of his corporations have been taken public and/or offered to public corporations, together with one within the medical-technology area that was offered to Varian, the main maker of linear accelerators utilized in most cancers remedy. Following his startup expertise, he retired to change into an Angel Investor in actual property and excessive tech. He got here out of retirement to discovered and fund AGT after assembly Roscoe Brady at NIH.
Katy Strei EVP, Human Resources/Global Communications & Public Affairs and Chief Human Resources Officer, Emergent BioSolutions
Ms. Strei joined Emergent BioSolutions in 2016 and has served as government vice chairman, human assets and chief human assets officer since April 2017. She beforehand served as senior vice chairman and chief human assets officer from January 2016 to March 2017. Previous to becoming a member of Emergent, Ms. Strei was an impartial marketing consultant, specializing in management and group growth from February 2014 to January 2016.
Judy Costello, Managing Director of Economic Development for BioHealth Innovation, Inc. (BHI)
Judy Costello is Managing Director of Financial Growth for BioHealth Innovation, Inc. (BHI). Previous to becoming a member of BHI, she served as Director of the Maryland Division of Commerce’s Workplace of BioHealth and Life Sciences and as Deputy Director of the division’s BioMaryland Heart. In these positions, she has labored to develop the area’s biohealth cluster by supporting business recruitment and retention, commercialization, workforce, non-dilutive and dilutive fundraising, worldwide comfortable touchdown, partnership, and promotion actions. She beforehand served as Govt Director of the Enterprise Alliance for Innovation and Entrepreneurship.
Jacob Greenwood, Director of Business Development in CRB’s Maryland Office
Jacob Greenwood is the Director of Enterprise Growth in CRB’s Maryland workplace. Born and raised in Northeast Baltimore Metropolis, he’s a life-long Marylander dedicated to seeing his state prosper. He earned a BA in Biology in 2008 from Goucher Faculty and has spent the final 12 years working within the Life Sciences business. Throughout that point, he has transitioned from the benchtop to the gross sales workplace. He’s enthusiastic about networking and is doing his half to enhance the BioHealth Capital Area’s ecosystem.
Ulyana Desiderio, Director of BioHealth and Life Sciences in the Maryland Department of Commerce
Ulyana Desiderio joined the Maryland Division of Commerce in April 2020 as Director of BioHealth and Life Sciences. She leads efforts that assist the expansion of Maryland’s life sciences neighborhood, together with job creation, capital funding, and new enterprise formation. Previous to becoming a member of Commerce, Ulyana served as Chief Scientific Officer for the American Society of Hematology (ASH), the biggest worldwide medical affiliation devoted to blood ailments. In her position, she developed and carried out methods that superior organizational scientific priorities in addition to federal insurance policies that have an effect on basic analysis and the observe of medication. Previous to becoming a member of ASH, Ulyana accomplished the Christine Mirzayan Science and Expertise Coverage Graduate Fellowship on the Nationwide Academy of Sciences’ Committee on Inhabitants, the place she was concerned in a undertaking on gathering, storing, and defending organic samples and knowledge. Ulyana holds B.S. levels in Organic Sciences and Chemistry from Drexel College and a Ph.D. in Biochemistry and Molecular Biology from the Johns Hopkins Bloomberg College of Public Well being.
Andrew Davis, Vice President at Scheer Partners
Andrew Davis is Vice President at Scheer Companions and helps run the scientific actual property observe. Andrew lives in Maryland however assists scientific corporations to establish, negotiate, and construct area within the BioHealth Capital Area, Philadelphia, Larger Pennsylvania, and Massachusetts.
Tammi Thomas, Vice President, Marketing & Communications at TEDCO
Tammi Thomas leads the event of TEDCO’s advertising and marketing and communications technique whereas contributing to the strategic operations and imaginative and prescient of the group. Her results-oriented method, proven-track document of constructing lasting relationships, and driving core enterprise goals by way of focused advertising and marketing methods are instrumental as she stewards the group by way of thrilling development to broaden assist for technology-based companies that thrive in Maryland and past.
Nick Droste, Emergent BioSolutions Postfill Manufacturing Supervisor
Nick Droste is a part of the postfill manufacturing crew on the Emergent BioSolutions Baltimore Camden website, the place he leads visible inspection operations for Emergent’s rising Contract Growth Manufacturing and Group (CDMO) efforts and in assist of their new partnership with the Biomedical Superior Analysis and Growth Authority (BARDA) COVID-19 vaccine growth operations. On the Camden website, he has spearheaded coaching initiatives and steady enchancment improvements to assist set up Camden as a visible inspection and packaging middle of excellence.
Mike O’Mara, VP of Industrial Business Services, Miltenyi Biotec
Mike O’Mara has greater than 27 years of expertise in biopharmaceutical contract manufacturing encompassing microbial, mammalian, and cell/Gene remedy manufacturing processes starting from Preclinical/Section I by way of Industrial. Previous to Miltenyi Biotec, Mike labored at Cytovance Biologics as Sr VP of Manufacturing Operations, DynPort Vaccine Company as Senior Director of Manufacturing, and was TissueGene’s Vice President of Manufacturing. Mike labored for Lonza Biologics for 18 years in a number of operations and manufacturing positions.
Amy Adams, Executive Director of the Institute for Biohealth Innovation at George Mason University
As Govt Director of the Institute for Biohealth Innovation at George Mason College, Amy Adams is answerable for nurturing and advancing biohealth analysis and innovation pursuits of greater than 250 school and 1000’s of scholars who characterize a broad vary of educational disciplines. Her position consists of fostering partnerships with business, healthcare, authorities, and educational companions.
Brian Hahn, Senior Vice President & CFO, GlycoMimetics
Mr. Hahn has greater than 15 years of senior monetary and operations expertise in rising organizations. He joined GlycoMimetics in 2010. Beforehand, Mr. Hahn served as government director of finance at Middlebrook Prescription drugs (previously Advancis Pharmaceutical), a publicly-traded specialty pharmaceutical firm. Presently, Mr. Hahn serves as co-chairman of the BIO Finance and Tax Committee, as a co-chairman of the Steering Committee of the Washington, DC chapter of the Affiliation for Bio Monetary Officers (ABFO), and in addition serves on the Securities and Change Commissions’ Advisory Committee on Small and Rising Corporations. He acquired a B.B.A. in Accounting from Shenandoah College and an M.B.A. from the College of Maryland.
Martha Schoonmaker, Executive Director, Pinkney Innovation Complex for Science and Technology at Montgomery College (PIC MC)
Martha Schoonmaker is the primary Govt Director for the PIC MC Basis, the entity that develops, manages, and markets the Germantown campus on behalf of Montgomery Faculty for firm places. PIC MC is an built-in educational, enterprise, and analysis campus and is the one neighborhood faculty with a hospital, Holy Cross Germantown Hospital, situated because the anchor resident companion. Ms. Schoonmaker manages contracts, leases, and partnerships with present resident companions, together with Holy Cross Germantown Hospital, and is answerable for the event of company and commerce affiliation partnerships that broaden internship, studying, and profession alternatives for college students inside PIC MC.
John Newby, CEO, Virginia Bio
John Newby is the CEO at Virginia Bio, the statewide non-profit commerce affiliation for the life science business. Roughly 300 corporations spanning biopharmaceuticals, medical units, med tech, diagnostics, digital well being, bioinformatics, agriculture, and industrial bio and associated fields are primarily based in Virginia, primarily clustered round analysis universities and medical establishments. Virginia Bio is the only state affiliate and works carefully with key nationwide business organizations BIO, AdvaMed, MDMA, PhRMA and We Work for Well being.
Ken Malone, Co-Founder, and Principal, Early Charm Ventures, LLC.
Ken Malone is a co-founder of Early Attraction Ventures, a enterprise studio based in 2012 in Baltimore (Attraction Metropolis) that converts science to enterprise. Early Attraction focuses on taking sensible scientific discoveries made at universities and turning them into corporations centered on development. They don’t chase fast exits. They construct corporations that create sustainable worth.
Chad Schneider, PE, MSE, President & Founder of Root3 Labs
Mr. Schneider is a mechanical design engineer with over 20 years of engineering expertise within the design of advanced electromechanical prototypes and merchandise. He earned a BS in mechanical engineering with Honors from the College of Maryland, Faculty Park, and an MSE in mechanical engineering from Johns Hopkins College with a concentrate on haptics and medical robotics. In 2012, he based Root3 Labs to concentrate on sensible R&D for the medical machine and protection industries. He’s skilled working with startups, producers, and State and Federal Authorities shoppers, named on 9 patents, a licensed sUAV Industrial Pilot, and a duly licensed skilled engineer by the State of Maryland.
Kurt Elam, Senior Director, Sales & Marketing for LabOwl
Kurt Elam joined ACC/Lab Owl in 2017 with 20+ years of specialty biopharmaceutical expertise, centered totally on oncology, infectious illness, and significant care/ICU medication. He has overseen and managed the profitable launch of over 16 new FDA permitted merchandise/compounds or new indications, and labored to realize formulary approval in managed care organizations, thereby bettering entry for sufferers. Previous to becoming a member of Lab Owl, Kurt labored with numerous biopharma corporations, together with Schering‐Plough, Astra‐Zeneca, EMD Serono, Amylin, and Actelion. He has a BA diploma from the College of Virginia.
Neil Sheppard, Immunologist, University of Pennsylvania
Neil Sheppard is an Immunologist educated within the UK on the Universities of Bristol and Oxford. He has over 18 years’ expertise within the fields of vaccines and immunotherapies, together with over a dozen years main drug discovery and growth applications in Massive Pharma and Biotech. Neil’s experience attracts on time within the UK, Australia, and each the East & West Coasts of the USA. Since 2015, Neil has centered solely on CAR and TCR remedy for most cancers, throughout which era he has led multidisciplinary groups and brought belongings into the clinic at GSK and Tmunity. In 2019 Neil returned to academia to take up a task on the UPenn Heart for Mobile Immunotherapies.
Stephen M. Jackson, Staff Scientist – Immunology, ABL, Inc.
“Born and raised in gang-infested South Central Los Angeles, I used to be surrounded by compassionate and risk-taking people who acknowledged and fertilized my love, expertise, and educational prowess. Collectively my tribe, for it takes one to boost one, helped present me with unimaginable alternatives to excel and proceed the battle for an ample life by way of well being, social consciousness, and creative expression. I, a Man who can also be Daring and Black, am a product of their braveness, compassion, endurance, imaginative and prescient, and love – Stephen M. Jackson, PhD”
Brian Darmody, CEO, Association of University Research Parks
Brian Darmody is CEO of AURP, a worldwide nonprofit representing analysis parks and innovation districts sponsored by universities, federal labs, communities, hospitals, and different establishments within the US and 12 different international locations. Beforehand Darmody served in a wide range of roles on the College of Maryland Faculty Park, together with within the President’s Workplace of Authorized Affairs, Workplace of Authorities Relations, Workplace of Analysis and Growth, Workplace of College Relations, and Heart for Utilized Coverage Research. Earlier than his work at UMD, Darmody labored on the US Well being Care Financing Fee, the US Home of Representatives, and the Maryland Home of Delegates.
Andy has labored with BioBuzz for the final decade to assist unfold the phrase of the BioHealth Capital Area even earlier than it was branded with that identify. His background consists of years at MedImmune supporting the Industrial Operations Group earlier than changing into a BioHealth Nomad working with varied shoppers in Operations, Communications and Strategic Companies.
[ad_2]
Source link
